Rodriguez Javier's Form 4 filing
BioXcel Therapeutics, Inc. (BTAIQ) · filed Jun 18, 2024
- Accession no.
- 0001104659-24-073001
- Filed
- Jun 18, 2024
- Trade date
- Jun 14-17, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $454.86. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rodriguez JavierCIK 0001847919 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | Common Stock | MOption exerciseDisposed | −521 | $0.00 | $0 | 3,648 | Direct | |
| Jun 15, 2024 | Common Stock | MOption exerciseDisposed | −562 | $0.00 | $0 | 6,188 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
Referenced by the price of 2 transactions in Table I.
Remarks
Chief Legal Officer, Senior Vice President and Corporate Secretary